Estudo da eficacia do Nilotinibe Concomitante a Quimioterapia no Tratamento de Pacientes Com Leucemia linfoblastica Aguda Filadelfia Positiva recem-diagnosticada
Phase of Trial: Phase I/II
Latest Information Update: 15 Jul 2015
At a glance
- Drugs Nilotinib (Primary)
- Indications Acute lymphoblastic leukaemia
- Focus Therapeutic Use
- Acronyms ANVISA
- 08 Jul 2015 Planned End Date changed from 1 Feb 2013 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 03 Jan 2013 Planned end date changed from 1 Apr 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 03 Jan 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.